Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

SNDA vs HCSG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HCSG Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 8–2 Matrix Metrics)

HCSG Overall Winner 6-Pillar Tally: SNDA 3 – 3 HCSG Matrix Metrics: SNDA 2 – 8 HCSG

As of Nov 17, 2026, Healthcare Services Group (HCSG) is the stronger overall head-to-head candidate over Sonida Senior Living, Inc. (SNDA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). SNDA carries a Unified Composite Score of 37.2/100 (SELL) at $32.42 (57.1x Forward P/E, -3.1% operating margin), whereas HCSG carries 45.3/100 (HOLD) at $24.62 (19.8x Forward P/E, 6.1% operating margin).

  • Growth vs. Quality Trade-Off: HCSG earns the overall head-to-head edge with a stronger Unified Composite Score (45.3/100 HOLD vs. SNDA 37.2/100 SELL) and 0.59β · 60% Vol risk profile, whereas SNDA leads top-line expansion (+131.2% YoY revenue growth, 2.04x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: SNDA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.9); meanwhile HCSG trades in a Markup technical trend (CONSOLIDATION options phase, RSI 55.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About SNDA vs HCSG
SNDA NYSE
Sonida Senior Living, Inc.
Services-Nursing & Personal Care Facilities
$32.42
-1.46% 1D
Market Cap $1.6B
TTM Revenue $594M
Forward P/E 57.1x
Beta / 30D Vol 0.49β · 48% Vol
Unified Composite Score
37.2 / 100 SELL
Tech 23.0 Fund 50.0 Flow 50.0 Mom 64.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 38
RSI-14: 37.9 · SMA20: $33.68 · SMA50: $35.89
HCSG NASDAQ Head-to-Head Winner
Healthcare Services Group
Services-Nursing & Personal Care Facilities
$24.62
-0.97% 1D
Market Cap $1.7B
TTM Revenue $1.88B
Forward P/E 19.8x
Beta / 30D Vol 0.59β · 60% Vol
Unified Composite Score
45.3 / 100 HOLD
Tech 33.0 Fund 43.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (5.1% over 20 days), RSI 55
RSI-14: 55.0 · SMA20: $24.83 · SMA50: $22.66

6-Pillar Scorecard Institutional Category Breakdown (SNDA 3 – 3 HCSG)

Columns: Metric · SNDA · HCSG
1. Valuation Multiples HCSG
Forward P/E 57.1x 19.8x
Trailing P/E 57.1x 16.8x
PEG Ratio 2.04x 2.39x
EV / Revenue 2.7x 0.8x
2. Growth & Scale SNDA
Revenue Growth (YoY) +131.2% +3.3%
Earnings Growth (YoY) -21.7% -39.0%
TTM Revenue (USD) $594M $1.88B
Market Cap $1.6B $1.7B
3. Profitability & Quality HCSG
Gross Margin 29.4% 16.1%
Operating Margin -3.1% 6.1%
Net Profit Margin -21.9% 5.6%
Return on Equity (ROE) -27.0% 20.4%
4. Balance Sheet & Cash Flow SNDA
Cash Generation (TTM) $103M EBITDA $107M
Cash Flow Margin 17.3% EBITDA Mgn 5.7%
Net Cash / Leverage $18.41 Book/Sh · -27.0% ROE $117M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HCSG
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 52.3% (8th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markup
6. R&D & Supply-Chain Moat SNDA
OpEx & R&D Intensity 32.5% of Rev ($193M) 10.0% of Rev ($188M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: SNDA (2) vs HCSG (8)
Institutional Metric SNDA HCSG Criterion Row Edge
Market Capitalization
Scale
$1.6B $1.7B Larger Scale HCSG
Trailing P/E Ratio
Valuation
57.1x 16.8x Lower Multiple HCSG
Forward P/E Ratio
Valuation
57.1x 19.8x Lower Multiple HCSG
Revenue Growth (YoY)
Growth
+131.2% +3.3% Higher Growth SNDA
Operating Margin (TTM)
Profitability
-3.1% 6.1% Higher Margin HCSG
Net Profit Margin
Profitability
-21.9% 5.6% Higher Margin HCSG
Return on Equity (ROE)
Capital Efficiency
-27.0% 20.4% Higher ROE HCSG
52-Week Range Position
Momentum
19% ($30–$44) 76% ($17–$27) Stronger Trend HCSG
Beta / 30D Volatility
Risk Regime
0.49β · 48% Vol 0.59β · 60% Vol Lower Realized Risk SNDA
Unified Institutional Score
Composite Signal
37.2 / 100 (SELL) 45.3 / 100 (HOLD) Higher Composite HCSG
Trailing 12M Revenue (USD)
Operating Scale
$594M $1.88B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
29.4% 16.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.04x PEG · 2.7x EV/Rev 2.39x PEG · 0.8x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$103M EBITDA ($18.41 Book/Sh · -27.0% ROE) $107M ($117M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HCSG +21.36 pp
SNDA: -4.73% · HCSG: +16.63%
3M Horizon HCSG +27.52 pp
SNDA: -20.15% · HCSG: +7.37%
6M Horizon HCSG +28.86 pp
SNDA: -10.44% · HCSG: +18.42%
1Y Horizon HCSG +41.4 pp
SNDA: +0.5% · HCSG: +41.9%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNDA vs HCSG. Trailing 12-month operating profitability (SNDA -3.1% vs HCSG 6.1%) and valuation multiples (SNDA 57.1x vs HCSG 19.8x Forward P/E) are benchmarked directly in Pillar 4 below.

SNDA ADR TTM Benchmark FX-Normalized USD
TTM Revenue$594M
Gross Margin29.4%
Op. Margin-3.1%
ROE / Fwd P/E-27.0% · 57.1x
HCSG ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.88B
Gross Margin16.1%
Op. Margin6.1%
ROE / Fwd P/E20.4% · 19.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
SNDA UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact SNDA Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HCSG CONSOLIDATION
100d in phase · OBV DISTRIBUTION
Current IV 52.3%
IV Percentile 8th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact HCSG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
SNDA Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $1.6B market capitalization and -3.1% operating margin.
OpEx & R&D Reinvestment 32.5% of Rev ($193M)
90D Engineering Disclosures 0 Published
HCSG Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $1.7B market capitalization and 6.1% operating margin.
OpEx & R&D Reinvestment 10.0% of Rev ($188M)
90D Engineering Disclosures 0 Published

Investor FAQ SNDA vs HCSG Key Questions & Quantitative Answers

As of Nov 17, 2026, Healthcare Services Group (HCSG) is the stronger overall head-to-head candidate over Sonida Senior Living, Inc. (SNDA) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Options & Positioning). SNDA carries a Unified Composite Score of 37.2/100 (SELL) at $32.42 (57.1x Forward P/E, -3.1% operating margin), whereas HCSG carries 45.3/100 (HOLD) at $24.62 (19.8x Forward P/E, 6.1% operating margin). Growth vs. Quality Trade-Off: HCSG earns the overall head-to-head edge with a stronger Unified Composite Score (45.3/100 HOLD vs. SNDA 37.2/100 SELL) and 0.59β · 60% Vol risk profile, whereas SNDA leads top-line expansion (+131.2% YoY revenue growth, 2.04x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: SNDA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.9); meanwhile HCSG trades in a Markup technical trend (CONSOLIDATION options phase, RSI 55.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

SNDA leads the Growth & Scale pillar: SNDA posts +131.2% YoY revenue growth and -21.7% YoY earnings growth on $594M TTM revenue (29.4% gross margin, -3.1% operating margin), compared with HCSG at +3.3% YoY revenue growth and -39.0% YoY earnings growth on $1.88B TTM revenue (16.1% gross margin, 6.1% operating margin). On trailing 12-month operating scale, SNDA generates $594M in USD-normalized revenue versus $1.88B for HCSG. In operating R&D and SG&A reinvestment, SNDA deploys 32.5% of Rev ($193M) (0 90-day corporate R&D disclosures) versus 10.0% of Rev ($188M) (0 disclosures) for HCSG.

HCSG screens cheaper on headline valuation multiples. SNDA trades at 57.1x Forward P/E, 57.1x Trailing P/E, 2.04x PEG, and 2.7x EV/Revenue (17.3% EBITDA margin), whereas HCSG trades at 19.8x Forward P/E, 16.8x Trailing P/E, 2.39x PEG, and 0.8x EV/Revenue (5.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against SNDA (-27.0% ROE) versus HCSG (20.4% ROE) capital efficiency.

In options market volatility and institutional positioning, SNDA carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 48% Vol realized risk). By comparison, HCSG carries 52.3% implied volatility (8th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.59β · 60% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.